Treace Medical Concepts, Inc. TMCI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 79.7%-0.5pp | 79.8%-0.6pp | 79.9%-0.7pp | 80.1%-0.6pp | 80.2%-0.7pp | |
| Operating margin | -26.9%-2.1pp | -25.5%+1.1pp | -22.1%+8.6pp | -22.4%+10.3pp | -24.8%+4.1pp | |
| Net margin | -29.4%-4.3pp | -27.7%-1.1pp | -22.9%+7.4pp | -23%+9.1pp | -25.1%+2.8pp | |
| EBITDA margin | -22.5%-2.0pp | -20.5%+2.1pp | -17.5%+9.2pp | -18%+11.0pp | -20.6%+5.1pp | |
| Free cash flow margin | -12.5%+5.0pp | -13.9%+9.4pp | -12%+9.3pp | -13.6%+7.3pp | -17.5%+2.1pp | |
| Returns | ||||||
| Return on equity | -66.9%-21.1pp | -58.9%-14.5pp | -51.6%-0.9pp | -46.9%+1.7pp | -45.7%-7.2pp | |
| Return on assets | -31.3%-7.7pp | -28.9%-5.2pp | -24.5%+2.7pp | -22.7%+4.0pp | -23.6%-1.4pp | |
| Return on invested capital | -37.1%-7.1pp | -33.9%-3.5pp | -30.8%+3.4pp | -29.6%+5.3pp | -30%-0.5pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1×+0.2× | 1.1×+0.2× | 1×+0.2× | 0.9×+0.1× | |
| Inventory turnover | 1.1×0.0× | 1.1×-0.1× | 1×0.0× | 1×-0.1× | 1.1×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3.6×-0.9× | 4.3×-0.3× | 3.4×-0.7× | 3.5×-0.3× | 4.5×+0.5× | |
| Quick ratio | 2.5×-0.8× | 3.1×-0.4× | 2.4×-0.6× | 2.5×-0.4× | 3.4×+0.1× | |
| Cash ratio | 0.3×-0.1× | 0.3×0.0× | 0.2×-0.1× | 0.2×-0.2× | 0.4×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×+0.3× | 0.8×+0.2× | 0.8×+0.1× | 0.7×+0.1× | 0.7×+0.1× | |
| Debt-to-assets | 0.4×+0.1× | 0.4×+0.1× | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Interest coverage | -10×0.0× | -10.2×+0.4× | -9.2×+2.7× | -9.1×+3.3× | -10×+0.9× | |
| Per Share | ||||||
| Book value per share | $1.20-28.9% | $1.38-24.1% | $1.40-16.7% | $1.55-14.2% | $1.68-17.8% | |
| Valuation | ||||||
| Market capitalization | $258.19M-26.6% | $156.11M-66.3% | $423.89M+17.7% | $372.4M-9.4% | $525.37M-34.8% | |
| Enterprise value | $320.25M-22.6% | $217.26M-58.4% | $486.58M+16.4% | $434.44M-6.1% | $581.36M-33.0% | |
| Price / sales | 1.3×-0.4× | 0.7×-1.5× | 1.9×+0.2× | 1.7×-0.3× | 2.5×-1.6× | |
| Price / book | 3.3×-0.3× | 1.8×-2.3× | 4.8×+1.3× | 3.8×+0.2× | 5×-1.4× | |
| EV / sales | 1.5×-0.4× | 1×-1.5× | 2.2×+0.2× | 2×-0.3× | 2.8×-1.7× | |
| Free cash flow yield | -10.1%-1.8pp | -18.9%-8.4pp | -6.2%+5.8pp | -7.8%+2.3pp | -7%-2.3pp | |
| Earnings yield | -23.6%-9.7pp | -37.8%-25.8pp | -11.8%+5.3pp | -13.2%+2.3pp | -10.1%-3.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Treace Medical Concepts, Inc. (TMCI) runs a 79.7% gross margin and a -26.9% operating margin, with a -29.4% net margin.
- Where do Treace Medical Concepts, Inc.'s ratios come from?
- Every ratio is computed from Treace Medical Concepts, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
